Normase Eps (Lactulose)

Lactulose is not absorbed in the small intestine; it reaches the colon where gut bacteria split it into short‑chain acids. These acids lower the colonic pH, converting ammonia to ammonium, which is poorly absorbed. The resulting osmotic gradient draws water into the lumen, softening stool and promoting evacuation while simultaneously decreasing systemic ammonia.

The dose of lactulose is individualized by the prescribing clinician based on the patient’s condition, age, renal function and response. Typical regimens start with a low dose that is gradually increased until the desired bowel movement frequency or ammonia reduction is achieved. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for lactulose during pregnancy and lactation are limited. It is generally categorized as a drug that should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Normase Eps with their healthcare provider.

To place an order, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Lactulose is an osmotic laxative that works by retaining water in the colon, whereas stimulant laxatives such as bisacodyl increase intestinal motility, and bulk‑forming agents add fiber to stool. Lactulose also lowers ammonia levels, a benefit not shared by most other laxatives. Its onset is slower than stimulant agents, but it is generally well‑tolerated for long‑term use.

Normase Eps should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed when not in use and store out of reach of children. No refrigeration is required for this oral formulation.

Normase Eps is taken orally, usually as a liquid or syrup. The product is measured with a calibrated dosing device or spoon, mixed with a small amount of water or juice if desired, and swallowed. It should be taken with or without food as directed by the prescriber, and the patient should stay well‑hydrated during therapy.

The most serious adverse events include severe dehydration, significant electrolyte disturbances (especially low potassium), and rare allergic reactions such as rash, facial swelling or difficulty breathing. Patients experiencing persistent diarrhea, dizziness, muscle weakness or signs of an allergic response should seek medical attention promptly.

Lactulose is contraindicated in individuals with known hypersensitivity to lactulose or any of its excipients. Patients with intestinal obstruction, perforated bowel, or severe inflammatory bowel disease should avoid its use. Caution is also advised for those with uncontrolled diabetes due to its carbohydrate content, and for patients with renal impairment where dose adjustment may be required.